Galič, Nazzareno <br/><br/>
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.  [electronic resource] 

 -  The New England journal of medicine  Aug 2015 
 - 834-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1413687  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Carbolines--adverse effects<br/>Disease Progression<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Hospitalization<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Phenylpropionates--adverse effects<br/>Pyridazines--adverse effects<br/>Risk Factors<br/>Tadalafil